KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Goodwill: 2018-2024

Historic Goodwill for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to $119.0 million.

  • Adaptive Biotechnologies' Goodwill changed negligibly% to $119.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $119.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Adaptive Biotechnologies' latest filing, its Goodwill stood at $119.0 million for FY2024, which was down 0.00% from $119.0 million recorded in FY2023.
  • Adaptive Biotechnologies' Goodwill's 5-year high stood at $119.0 million during FY2020, with a 5-year trough of $119.0 million in FY2020.
  • Moreover, its 3-year median value for Goodwill was $119.0 million (2024), whereas its average is $119.0 million.